Table 1 Clinical and phenotypic features of patients with Cushing’s disease

From: Identification of recurrent USP48 and BRAF mutations in Cushing’s disease

Characteristics

Wild-type (n = 55)

BRAF V600E (n = 15)

P value

USP48 mutation (n = 21)

P value

Gender

  Male

16

4

0.856a

3

0.187a

  Female

39

11

 

18

 

Age at diagnosis

  Median

36

36

0.769b

41

0.5b

  Interquartile range

27–46

26–46

 

26.5–49.5

 

Clinical course

  Median

36

24

0.438b

12

0.06b

  Interquartile range

12–84

8–60

 

3.5–48

 

Diameter (mm)

  Median

10

7.5

0.502b

8.5

0.437b

  Interquartile range

5–22

3.5–22

 

6.4–10

 

Midnight plasma corticotropin (ACTH) (pg/ml)

  Median

60.4

140.5

0.023b

48.45

0.307b

  Interquartile range

49.05–107.47

82.15–220.04

 

31.57–92.63

 

Midnight serum cortisol (μg/dl)

  Median

17.5

23.82

0.007b

17.7

0.673b

  Interquartile range

14.34–28.05

21.82–39.10

 

13.74–33.88

 

Urinary free cortisol (μg/24 h)

  Median

510.97

488.94

0.936b

415.66

0.505b

  Interquartile range

273.69–1133.15

405.37–1116.78

 

215.28–894.86

 

Invasiveness

  Yes

13

2

0.546a

4

0.816a

  No

39

10

 

14

 

Immediate postoperative biochemical remission (%)

  Yes

24

6

0.951a

13

0.328a

  No

25

6

 

8

 

Postoperative recurrence (%)

  Yes

2

1

0.937a

0

0.224a

  No

9

4

 

8

 
  1. aValues were determined as compared to wild-type (Pearson's χ2 test)
  2. bValues were determined as compared to wild-type (Mann–Whitney U-test)